MicroRNA-613 is downregulated in HCMVpositive glioblastoma and inhibits tumour progression by targeting arginase-2

15Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Glioblastoma is the most common and malignant tumour that occurs primarily in nervous system and has a high morbidity. Research on glioblastoma has recently focused on human cytomegalovirus, belonging to the beta subfamily of Herpesviridae that plays crucial roles in cancer development and progression. This study aimed to investigate the role of human cytomegalovirus-associated microRNA-613 in glioblastoma. In this study, we demonstrate that microRNA-613 expression was frequently reduced in human cytomegalovirus-positive glioblastoma specimens/cells compared with human cytomegalovirus-negative glioblastoma tissue/cells, and a significant correlation was observed between the reduction in microRNA-613 expression and the presence of unfavourable variables, including tumour size (p = 0.0118), World Health Organization stage (p = 0.0169), the overall survival (p = 0.0107) and disease-free (p = 0.0159) survival of patients. Overexpression of microRNA-613 in the glioblastoma cell lines U87 and U251 retarded cell growth and induced cell apoptosis. Upregulation of microRNA-613 inhibited glioblastoma cell clone formation, invasion and migration. Furthermore, we demonstrated that arginase-2 was directly regulated by microRNA-613 and played an essential role in mediating the biological effects of microRNA-613 in glioblastoma. Re-expression of arginase-2 markedly reversed the inhibitory properties of microRNA-613 in glioblastoma cells. Taken together, our data provide compelling evidence that human cytomegalovirus reduced the level of microRNA-613 which functions as an anti-onco-miRNA in glioblastoma, primarily by downregulating the expression of arginase-2.

References Powered by Scopus

Regulation of immune responses by L-arginine metabolism

1478Citations
N/AReaders
Get full text

MicroRNA Regulation of RNA Virus Replication and Pathogenesis

303Citations
N/AReaders
Get full text

Arginases I and II: Do their functions overlap?

233Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The role of CMV in glioblastoma and implications for immunotherapeutic strategies

43Citations
N/AReaders
Get full text

miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets

36Citations
N/AReaders
Get full text

Arginine Metabolism and Its Potential in Treatment of Colorectal Cancer

30Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wang, Y., Zhao, P., Qian, D., Hu, M., Zhang, L., Shi, H., & Wang, B. (2017). MicroRNA-613 is downregulated in HCMVpositive glioblastoma and inhibits tumour progression by targeting arginase-2. Tumor Biology, 39(7), 1–10. https://doi.org/10.1177/1010428317712512

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

78%

Professor / Associate Prof. 1

11%

Researcher 1

11%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 5

42%

Biochemistry, Genetics and Molecular Bi... 4

33%

Medicine and Dentistry 2

17%

Chemistry 1

8%

Save time finding and organizing research with Mendeley

Sign up for free